Therefore, among the approximately 150,000 new CRC cases diagnosed in the United States in 2008 (Jemal et al., 2008), at least 20,000 patients were expected to have sporadic MMR-deficient tumors (Sinicrope et al., 2010). This evidence concerns the gene MRC1 and colorectal carcinoma.